Global Molecular Diagnostics Point of Care Market Growth (Status and Outlook) 2026-2032
The global Molecular Diagnostics Point of Care market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The Molecular Diagnostics Point of Care enables physicians to improve the standard of care by combining rapid diagnosis with treatment decisions during the first patient visit.
United States market for Molecular Diagnostics Point of Care is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Molecular Diagnostics Point of Care is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Molecular Diagnostics Point of Care is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Molecular Diagnostics Point of Care players cover Abbott Laboratories, Abaxis, Bayer Healthcare, Bio-Rad Laboratories, Becton Dickinson and Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Molecular Diagnostics Point of Care Industry Forecast” looks at past sales and reviews total world Molecular Diagnostics Point of Care sales in 2025, providing a comprehensive analysis by region and market sector of projected Molecular Diagnostics Point of Care sales for 2026 through 2032. With Molecular Diagnostics Point of Care sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Diagnostics Point of Care industry.
This Insight Report provides a comprehensive analysis of the global Molecular Diagnostics Point of Care landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Molecular Diagnostics Point of Care portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Diagnostics Point of Care market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Diagnostics Point of Care and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Diagnostics Point of Care.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Diagnostics Point of Care market by product type, application, key players and key regions and countries.
Segmentation by Type:
The Molecular Diagnostics Point of Care enables physicians to improve the standard of care by combining rapid diagnosis with treatment decisions during the first patient visit.
United States market for Molecular Diagnostics Point of Care is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Molecular Diagnostics Point of Care is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Molecular Diagnostics Point of Care is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Molecular Diagnostics Point of Care players cover Abbott Laboratories, Abaxis, Bayer Healthcare, Bio-Rad Laboratories, Becton Dickinson and Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Molecular Diagnostics Point of Care Industry Forecast” looks at past sales and reviews total world Molecular Diagnostics Point of Care sales in 2025, providing a comprehensive analysis by region and market sector of projected Molecular Diagnostics Point of Care sales for 2026 through 2032. With Molecular Diagnostics Point of Care sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Diagnostics Point of Care industry.
This Insight Report provides a comprehensive analysis of the global Molecular Diagnostics Point of Care landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Molecular Diagnostics Point of Care portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Diagnostics Point of Care market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Diagnostics Point of Care and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Diagnostics Point of Care.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Diagnostics Point of Care market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Assays and Kits
- Instruments and Analyzers
- Software and Services
- Others
- Tumor
- Hematology
- Endocrinology
- Infectious Disease
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Laboratories
- Abaxis
- Bayer Healthcare
- Bio-Rad Laboratories
- Becton Dickinson and Company
- Binx Health
- BioMerieux
- Co-Diagnostics
- DanaherCorporation
- Dako
- F. Hoffmann
- OraSure Technologies
- Roche Diagnostics
- Nipro Diagnostics
- Genestat
- Meridian Bioscience
- Molbio Diagnostics
- Siemens Healthcare
- Thermo Fisher Scientific
- Visby Medical
- Wuhan Easy Diagnosis Biomedicine
- Beijing Tiandz
- Beijing Content
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Molecular Diagnostics Point of Care Market Size (2021-2032)
2.1.2 Molecular Diagnostics Point of Care Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Molecular Diagnostics Point of Care by Country/Region (2021, 2025 & 2032)
2.2 Molecular Diagnostics Point of Care Segment by Type
2.2.1 Assays and Kits
2.2.2 Instruments and Analyzers
2.2.3 Software and Services
2.2.4 Others
2.2.5 Molecular Diagnostics Point of Care Market Size by Type
2.2.5.1 Molecular Diagnostics Point of Care Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Molecular Diagnostics Point of Care Market Size Market Share by Type (2021-2026)
2.3 Molecular Diagnostics Point of Care Segment by Application
2.3.1 Tumor
2.3.2 Hematology
2.3.3 Endocrinology
2.3.4 Infectious Disease
2.3.5 Others
2.3.6 Molecular Diagnostics Point of Care Market Size by Application
2.3.6.1 Molecular Diagnostics Point of Care Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.6.2 Global Molecular Diagnostics Point of Care Market Size Market Share by Application (2021-2026)
3 MOLECULAR DIAGNOSTICS POINT OF CARE MARKET SIZE BY PLAYER
3.1 Molecular Diagnostics Point of Care Market Size Market Share by Player
3.1.1 Global Molecular Diagnostics Point of Care Revenue by Player (2021-2026)
3.1.2 Global Molecular Diagnostics Point of Care Revenue Market Share by Player (2021-2026)
3.2 Global Molecular Diagnostics Point of Care Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MOLECULAR DIAGNOSTICS POINT OF CARE BY REGION
4.1 Molecular Diagnostics Point of Care Market Size by Region (2021-2026)
4.2 Global Molecular Diagnostics Point of Care Annual Revenue by Country/Region (2021-2026)
4.3 Americas Molecular Diagnostics Point of Care Market Size Growth (2021-2026)
4.4 APAC Molecular Diagnostics Point of Care Market Size Growth (2021-2026)
4.5 Europe Molecular Diagnostics Point of Care Market Size Growth (2021-2026)
4.6 Middle East & Africa Molecular Diagnostics Point of Care Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Molecular Diagnostics Point of Care Market Size by Country (2021-2026)
5.2 Americas Molecular Diagnostics Point of Care Market Size by Type (2021-2026)
5.3 Americas Molecular Diagnostics Point of Care Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Diagnostics Point of Care Market Size by Region (2021-2026)
6.2 APAC Molecular Diagnostics Point of Care Market Size by Type (2021-2026)
6.3 APAC Molecular Diagnostics Point of Care Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Molecular Diagnostics Point of Care Market Size by Country (2021-2026)
7.2 Europe Molecular Diagnostics Point of Care Market Size by Type (2021-2026)
7.3 Europe Molecular Diagnostics Point of Care Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Molecular Diagnostics Point of Care by Region (2021-2026)
8.2 Middle East & Africa Molecular Diagnostics Point of Care Market Size by Type (2021-2026)
8.3 Middle East & Africa Molecular Diagnostics Point of Care Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MOLECULAR DIAGNOSTICS POINT OF CARE MARKET FORECAST
10.1 Global Molecular Diagnostics Point of Care Forecast by Region (2027-2032)
10.1.1 Global Molecular Diagnostics Point of Care Forecast by Region (2027-2032)
10.1.2 Americas Molecular Diagnostics Point of Care Forecast
10.1.3 APAC Molecular Diagnostics Point of Care Forecast
10.1.4 Europe Molecular Diagnostics Point of Care Forecast
10.1.5 Middle East & Africa Molecular Diagnostics Point of Care Forecast
10.2 Americas Molecular Diagnostics Point of Care Forecast by Country (2027-2032)
10.2.1 United States Market Molecular Diagnostics Point of Care Forecast
10.2.2 Canada Market Molecular Diagnostics Point of Care Forecast
10.2.3 Mexico Market Molecular Diagnostics Point of Care Forecast
10.2.4 Brazil Market Molecular Diagnostics Point of Care Forecast
10.3 APAC Molecular Diagnostics Point of Care Forecast by Region (2027-2032)
10.3.1 China Molecular Diagnostics Point of Care Market Forecast
10.3.2 Japan Market Molecular Diagnostics Point of Care Forecast
10.3.3 Korea Market Molecular Diagnostics Point of Care Forecast
10.3.4 Southeast Asia Market Molecular Diagnostics Point of Care Forecast
10.3.5 India Market Molecular Diagnostics Point of Care Forecast
10.3.6 Australia Market Molecular Diagnostics Point of Care Forecast
10.4 Europe Molecular Diagnostics Point of Care Forecast by Country (2027-2032)
10.4.1 Germany Market Molecular Diagnostics Point of Care Forecast
10.4.2 France Market Molecular Diagnostics Point of Care Forecast
10.4.3 UK Market Molecular Diagnostics Point of Care Forecast
10.4.4 Italy Market Molecular Diagnostics Point of Care Forecast
10.4.5 Russia Market Molecular Diagnostics Point of Care Forecast
10.5 Middle East & Africa Molecular Diagnostics Point of Care Forecast by Region (2027-2032)
10.5.1 Egypt Market Molecular Diagnostics Point of Care Forecast
10.5.2 South Africa Market Molecular Diagnostics Point of Care Forecast
10.5.3 Israel Market Molecular Diagnostics Point of Care Forecast
10.5.4 Turkey Market Molecular Diagnostics Point of Care Forecast
10.6 Global Molecular Diagnostics Point of Care Forecast by Type (2027-2032)
10.7 Global Molecular Diagnostics Point of Care Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Molecular Diagnostics Point of Care Forecast
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Molecular Diagnostics Point of Care Product Offered
11.1.3 Abbott Laboratories Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Abaxis
11.2.1 Abaxis Company Information
11.2.2 Abaxis Molecular Diagnostics Point of Care Product Offered
11.2.3 Abaxis Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Abaxis Main Business Overview
11.2.5 Abaxis Latest Developments
11.3 Bayer Healthcare
11.3.1 Bayer Healthcare Company Information
11.3.2 Bayer Healthcare Molecular Diagnostics Point of Care Product Offered
11.3.3 Bayer Healthcare Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bayer Healthcare Main Business Overview
11.3.5 Bayer Healthcare Latest Developments
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Information
11.4.2 Bio-Rad Laboratories Molecular Diagnostics Point of Care Product Offered
11.4.3 Bio-Rad Laboratories Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Bio-Rad Laboratories Main Business Overview
11.4.5 Bio-Rad Laboratories Latest Developments
11.5 Becton Dickinson and Company
11.5.1 Becton Dickinson and Company Company Information
11.5.2 Becton Dickinson and Company Molecular Diagnostics Point of Care Product Offered
11.5.3 Becton Dickinson and Company Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Becton Dickinson and Company Main Business Overview
11.5.5 Becton Dickinson and Company Latest Developments
11.6 Binx Health
11.6.1 Binx Health Company Information
11.6.2 Binx Health Molecular Diagnostics Point of Care Product Offered
11.6.3 Binx Health Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Binx Health Main Business Overview
11.6.5 Binx Health Latest Developments
11.7 BioMerieux
11.7.1 BioMerieux Company Information
11.7.2 BioMerieux Molecular Diagnostics Point of Care Product Offered
11.7.3 BioMerieux Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 BioMerieux Main Business Overview
11.7.5 BioMerieux Latest Developments
11.8 Co-Diagnostics
11.8.1 Co-Diagnostics Company Information
11.8.2 Co-Diagnostics Molecular Diagnostics Point of Care Product Offered
11.8.3 Co-Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Co-Diagnostics Main Business Overview
11.8.5 Co-Diagnostics Latest Developments
11.9 DanaherCorporation
11.9.1 DanaherCorporation Company Information
11.9.2 DanaherCorporation Molecular Diagnostics Point of Care Product Offered
11.9.3 DanaherCorporation Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 DanaherCorporation Main Business Overview
11.9.5 DanaherCorporation Latest Developments
11.10 Dako
11.10.1 Dako Company Information
11.10.2 Dako Molecular Diagnostics Point of Care Product Offered
11.10.3 Dako Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Dako Main Business Overview
11.10.5 Dako Latest Developments
11.11 F. Hoffmann
11.11.1 F. Hoffmann Company Information
11.11.2 F. Hoffmann Molecular Diagnostics Point of Care Product Offered
11.11.3 F. Hoffmann Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 F. Hoffmann Main Business Overview
11.11.5 F. Hoffmann Latest Developments
11.12 OraSure Technologies
11.12.1 OraSure Technologies Company Information
11.12.2 OraSure Technologies Molecular Diagnostics Point of Care Product Offered
11.12.3 OraSure Technologies Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 OraSure Technologies Main Business Overview
11.12.5 OraSure Technologies Latest Developments
11.13 Roche Diagnostics
11.13.1 Roche Diagnostics Company Information
11.13.2 Roche Diagnostics Molecular Diagnostics Point of Care Product Offered
11.13.3 Roche Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Roche Diagnostics Main Business Overview
11.13.5 Roche Diagnostics Latest Developments
11.14 Nipro Diagnostics
11.14.1 Nipro Diagnostics Company Information
11.14.2 Nipro Diagnostics Molecular Diagnostics Point of Care Product Offered
11.14.3 Nipro Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Nipro Diagnostics Main Business Overview
11.14.5 Nipro Diagnostics Latest Developments
11.15 Genestat
11.15.1 Genestat Company Information
11.15.2 Genestat Molecular Diagnostics Point of Care Product Offered
11.15.3 Genestat Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Genestat Main Business Overview
11.15.5 Genestat Latest Developments
11.16 Meridian Bioscience
11.16.1 Meridian Bioscience Company Information
11.16.2 Meridian Bioscience Molecular Diagnostics Point of Care Product Offered
11.16.3 Meridian Bioscience Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Meridian Bioscience Main Business Overview
11.16.5 Meridian Bioscience Latest Developments
11.17 Molbio Diagnostics
11.17.1 Molbio Diagnostics Company Information
11.17.2 Molbio Diagnostics Molecular Diagnostics Point of Care Product Offered
11.17.3 Molbio Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Molbio Diagnostics Main Business Overview
11.17.5 Molbio Diagnostics Latest Developments
11.18 Siemens Healthcare
11.18.1 Siemens Healthcare Company Information
11.18.2 Siemens Healthcare Molecular Diagnostics Point of Care Product Offered
11.18.3 Siemens Healthcare Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Siemens Healthcare Main Business Overview
11.18.5 Siemens Healthcare Latest Developments
11.19 Thermo Fisher Scientific
11.19.1 Thermo Fisher Scientific Company Information
11.19.2 Thermo Fisher Scientific Molecular Diagnostics Point of Care Product Offered
11.19.3 Thermo Fisher Scientific Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Thermo Fisher Scientific Main Business Overview
11.19.5 Thermo Fisher Scientific Latest Developments
11.20 Visby Medical
11.20.1 Visby Medical Company Information
11.20.2 Visby Medical Molecular Diagnostics Point of Care Product Offered
11.20.3 Visby Medical Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Visby Medical Main Business Overview
11.20.5 Visby Medical Latest Developments
11.21 Wuhan Easy Diagnosis Biomedicine
11.21.1 Wuhan Easy Diagnosis Biomedicine Company Information
11.21.2 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Product Offered
11.21.3 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Wuhan Easy Diagnosis Biomedicine Main Business Overview
11.21.5 Wuhan Easy Diagnosis Biomedicine Latest Developments
11.22 Beijing Tiandz
11.22.1 Beijing Tiandz Company Information
11.22.2 Beijing Tiandz Molecular Diagnostics Point of Care Product Offered
11.22.3 Beijing Tiandz Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Beijing Tiandz Main Business Overview
11.22.5 Beijing Tiandz Latest Developments
11.23 Beijing Content
11.23.1 Beijing Content Company Information
11.23.2 Beijing Content Molecular Diagnostics Point of Care Product Offered
11.23.3 Beijing Content Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Beijing Content Main Business Overview
11.23.5 Beijing Content Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Molecular Diagnostics Point of Care Market Size (2021-2032)
2.1.2 Molecular Diagnostics Point of Care Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Molecular Diagnostics Point of Care by Country/Region (2021, 2025 & 2032)
2.2 Molecular Diagnostics Point of Care Segment by Type
2.2.1 Assays and Kits
2.2.2 Instruments and Analyzers
2.2.3 Software and Services
2.2.4 Others
2.2.5 Molecular Diagnostics Point of Care Market Size by Type
2.2.5.1 Molecular Diagnostics Point of Care Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Molecular Diagnostics Point of Care Market Size Market Share by Type (2021-2026)
2.3 Molecular Diagnostics Point of Care Segment by Application
2.3.1 Tumor
2.3.2 Hematology
2.3.3 Endocrinology
2.3.4 Infectious Disease
2.3.5 Others
2.3.6 Molecular Diagnostics Point of Care Market Size by Application
2.3.6.1 Molecular Diagnostics Point of Care Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.6.2 Global Molecular Diagnostics Point of Care Market Size Market Share by Application (2021-2026)
3 MOLECULAR DIAGNOSTICS POINT OF CARE MARKET SIZE BY PLAYER
3.1 Molecular Diagnostics Point of Care Market Size Market Share by Player
3.1.1 Global Molecular Diagnostics Point of Care Revenue by Player (2021-2026)
3.1.2 Global Molecular Diagnostics Point of Care Revenue Market Share by Player (2021-2026)
3.2 Global Molecular Diagnostics Point of Care Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MOLECULAR DIAGNOSTICS POINT OF CARE BY REGION
4.1 Molecular Diagnostics Point of Care Market Size by Region (2021-2026)
4.2 Global Molecular Diagnostics Point of Care Annual Revenue by Country/Region (2021-2026)
4.3 Americas Molecular Diagnostics Point of Care Market Size Growth (2021-2026)
4.4 APAC Molecular Diagnostics Point of Care Market Size Growth (2021-2026)
4.5 Europe Molecular Diagnostics Point of Care Market Size Growth (2021-2026)
4.6 Middle East & Africa Molecular Diagnostics Point of Care Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Molecular Diagnostics Point of Care Market Size by Country (2021-2026)
5.2 Americas Molecular Diagnostics Point of Care Market Size by Type (2021-2026)
5.3 Americas Molecular Diagnostics Point of Care Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Diagnostics Point of Care Market Size by Region (2021-2026)
6.2 APAC Molecular Diagnostics Point of Care Market Size by Type (2021-2026)
6.3 APAC Molecular Diagnostics Point of Care Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Molecular Diagnostics Point of Care Market Size by Country (2021-2026)
7.2 Europe Molecular Diagnostics Point of Care Market Size by Type (2021-2026)
7.3 Europe Molecular Diagnostics Point of Care Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Molecular Diagnostics Point of Care by Region (2021-2026)
8.2 Middle East & Africa Molecular Diagnostics Point of Care Market Size by Type (2021-2026)
8.3 Middle East & Africa Molecular Diagnostics Point of Care Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MOLECULAR DIAGNOSTICS POINT OF CARE MARKET FORECAST
10.1 Global Molecular Diagnostics Point of Care Forecast by Region (2027-2032)
10.1.1 Global Molecular Diagnostics Point of Care Forecast by Region (2027-2032)
10.1.2 Americas Molecular Diagnostics Point of Care Forecast
10.1.3 APAC Molecular Diagnostics Point of Care Forecast
10.1.4 Europe Molecular Diagnostics Point of Care Forecast
10.1.5 Middle East & Africa Molecular Diagnostics Point of Care Forecast
10.2 Americas Molecular Diagnostics Point of Care Forecast by Country (2027-2032)
10.2.1 United States Market Molecular Diagnostics Point of Care Forecast
10.2.2 Canada Market Molecular Diagnostics Point of Care Forecast
10.2.3 Mexico Market Molecular Diagnostics Point of Care Forecast
10.2.4 Brazil Market Molecular Diagnostics Point of Care Forecast
10.3 APAC Molecular Diagnostics Point of Care Forecast by Region (2027-2032)
10.3.1 China Molecular Diagnostics Point of Care Market Forecast
10.3.2 Japan Market Molecular Diagnostics Point of Care Forecast
10.3.3 Korea Market Molecular Diagnostics Point of Care Forecast
10.3.4 Southeast Asia Market Molecular Diagnostics Point of Care Forecast
10.3.5 India Market Molecular Diagnostics Point of Care Forecast
10.3.6 Australia Market Molecular Diagnostics Point of Care Forecast
10.4 Europe Molecular Diagnostics Point of Care Forecast by Country (2027-2032)
10.4.1 Germany Market Molecular Diagnostics Point of Care Forecast
10.4.2 France Market Molecular Diagnostics Point of Care Forecast
10.4.3 UK Market Molecular Diagnostics Point of Care Forecast
10.4.4 Italy Market Molecular Diagnostics Point of Care Forecast
10.4.5 Russia Market Molecular Diagnostics Point of Care Forecast
10.5 Middle East & Africa Molecular Diagnostics Point of Care Forecast by Region (2027-2032)
10.5.1 Egypt Market Molecular Diagnostics Point of Care Forecast
10.5.2 South Africa Market Molecular Diagnostics Point of Care Forecast
10.5.3 Israel Market Molecular Diagnostics Point of Care Forecast
10.5.4 Turkey Market Molecular Diagnostics Point of Care Forecast
10.6 Global Molecular Diagnostics Point of Care Forecast by Type (2027-2032)
10.7 Global Molecular Diagnostics Point of Care Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Molecular Diagnostics Point of Care Forecast
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Molecular Diagnostics Point of Care Product Offered
11.1.3 Abbott Laboratories Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Abaxis
11.2.1 Abaxis Company Information
11.2.2 Abaxis Molecular Diagnostics Point of Care Product Offered
11.2.3 Abaxis Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Abaxis Main Business Overview
11.2.5 Abaxis Latest Developments
11.3 Bayer Healthcare
11.3.1 Bayer Healthcare Company Information
11.3.2 Bayer Healthcare Molecular Diagnostics Point of Care Product Offered
11.3.3 Bayer Healthcare Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bayer Healthcare Main Business Overview
11.3.5 Bayer Healthcare Latest Developments
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Information
11.4.2 Bio-Rad Laboratories Molecular Diagnostics Point of Care Product Offered
11.4.3 Bio-Rad Laboratories Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Bio-Rad Laboratories Main Business Overview
11.4.5 Bio-Rad Laboratories Latest Developments
11.5 Becton Dickinson and Company
11.5.1 Becton Dickinson and Company Company Information
11.5.2 Becton Dickinson and Company Molecular Diagnostics Point of Care Product Offered
11.5.3 Becton Dickinson and Company Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Becton Dickinson and Company Main Business Overview
11.5.5 Becton Dickinson and Company Latest Developments
11.6 Binx Health
11.6.1 Binx Health Company Information
11.6.2 Binx Health Molecular Diagnostics Point of Care Product Offered
11.6.3 Binx Health Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Binx Health Main Business Overview
11.6.5 Binx Health Latest Developments
11.7 BioMerieux
11.7.1 BioMerieux Company Information
11.7.2 BioMerieux Molecular Diagnostics Point of Care Product Offered
11.7.3 BioMerieux Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 BioMerieux Main Business Overview
11.7.5 BioMerieux Latest Developments
11.8 Co-Diagnostics
11.8.1 Co-Diagnostics Company Information
11.8.2 Co-Diagnostics Molecular Diagnostics Point of Care Product Offered
11.8.3 Co-Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Co-Diagnostics Main Business Overview
11.8.5 Co-Diagnostics Latest Developments
11.9 DanaherCorporation
11.9.1 DanaherCorporation Company Information
11.9.2 DanaherCorporation Molecular Diagnostics Point of Care Product Offered
11.9.3 DanaherCorporation Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 DanaherCorporation Main Business Overview
11.9.5 DanaherCorporation Latest Developments
11.10 Dako
11.10.1 Dako Company Information
11.10.2 Dako Molecular Diagnostics Point of Care Product Offered
11.10.3 Dako Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Dako Main Business Overview
11.10.5 Dako Latest Developments
11.11 F. Hoffmann
11.11.1 F. Hoffmann Company Information
11.11.2 F. Hoffmann Molecular Diagnostics Point of Care Product Offered
11.11.3 F. Hoffmann Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 F. Hoffmann Main Business Overview
11.11.5 F. Hoffmann Latest Developments
11.12 OraSure Technologies
11.12.1 OraSure Technologies Company Information
11.12.2 OraSure Technologies Molecular Diagnostics Point of Care Product Offered
11.12.3 OraSure Technologies Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 OraSure Technologies Main Business Overview
11.12.5 OraSure Technologies Latest Developments
11.13 Roche Diagnostics
11.13.1 Roche Diagnostics Company Information
11.13.2 Roche Diagnostics Molecular Diagnostics Point of Care Product Offered
11.13.3 Roche Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Roche Diagnostics Main Business Overview
11.13.5 Roche Diagnostics Latest Developments
11.14 Nipro Diagnostics
11.14.1 Nipro Diagnostics Company Information
11.14.2 Nipro Diagnostics Molecular Diagnostics Point of Care Product Offered
11.14.3 Nipro Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Nipro Diagnostics Main Business Overview
11.14.5 Nipro Diagnostics Latest Developments
11.15 Genestat
11.15.1 Genestat Company Information
11.15.2 Genestat Molecular Diagnostics Point of Care Product Offered
11.15.3 Genestat Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Genestat Main Business Overview
11.15.5 Genestat Latest Developments
11.16 Meridian Bioscience
11.16.1 Meridian Bioscience Company Information
11.16.2 Meridian Bioscience Molecular Diagnostics Point of Care Product Offered
11.16.3 Meridian Bioscience Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Meridian Bioscience Main Business Overview
11.16.5 Meridian Bioscience Latest Developments
11.17 Molbio Diagnostics
11.17.1 Molbio Diagnostics Company Information
11.17.2 Molbio Diagnostics Molecular Diagnostics Point of Care Product Offered
11.17.3 Molbio Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Molbio Diagnostics Main Business Overview
11.17.5 Molbio Diagnostics Latest Developments
11.18 Siemens Healthcare
11.18.1 Siemens Healthcare Company Information
11.18.2 Siemens Healthcare Molecular Diagnostics Point of Care Product Offered
11.18.3 Siemens Healthcare Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Siemens Healthcare Main Business Overview
11.18.5 Siemens Healthcare Latest Developments
11.19 Thermo Fisher Scientific
11.19.1 Thermo Fisher Scientific Company Information
11.19.2 Thermo Fisher Scientific Molecular Diagnostics Point of Care Product Offered
11.19.3 Thermo Fisher Scientific Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Thermo Fisher Scientific Main Business Overview
11.19.5 Thermo Fisher Scientific Latest Developments
11.20 Visby Medical
11.20.1 Visby Medical Company Information
11.20.2 Visby Medical Molecular Diagnostics Point of Care Product Offered
11.20.3 Visby Medical Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Visby Medical Main Business Overview
11.20.5 Visby Medical Latest Developments
11.21 Wuhan Easy Diagnosis Biomedicine
11.21.1 Wuhan Easy Diagnosis Biomedicine Company Information
11.21.2 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Product Offered
11.21.3 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Wuhan Easy Diagnosis Biomedicine Main Business Overview
11.21.5 Wuhan Easy Diagnosis Biomedicine Latest Developments
11.22 Beijing Tiandz
11.22.1 Beijing Tiandz Company Information
11.22.2 Beijing Tiandz Molecular Diagnostics Point of Care Product Offered
11.22.3 Beijing Tiandz Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Beijing Tiandz Main Business Overview
11.22.5 Beijing Tiandz Latest Developments
11.23 Beijing Content
11.23.1 Beijing Content Company Information
11.23.2 Beijing Content Molecular Diagnostics Point of Care Product Offered
11.23.3 Beijing Content Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Beijing Content Main Business Overview
11.23.5 Beijing Content Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Molecular Diagnostics Point of Care Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Molecular Diagnostics Point of Care Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Assays and Kits
Table 4. Major Players of Instruments and Analyzers
Table 5. Major Players of Software and Services
Table 6. Major Players of Others
Table 7. Molecular Diagnostics Point of Care Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Molecular Diagnostics Point of Care Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Molecular Diagnostics Point of Care Market Size Market Share by Type (2021-2026)
Table 10. Molecular Diagnostics Point of Care Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Molecular Diagnostics Point of Care Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Molecular Diagnostics Point of Care Market Size Market Share by Application (2021-2026)
Table 13. Global Molecular Diagnostics Point of Care Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Molecular Diagnostics Point of Care Revenue Market Share by Player (2021-2026)
Table 15. Molecular Diagnostics Point of Care Key Players Head office and Products Offered
Table 16. Molecular Diagnostics Point of Care Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Molecular Diagnostics Point of Care Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Molecular Diagnostics Point of Care Market Size Market Share by Region (2021-2026)
Table 21. Global Molecular Diagnostics Point of Care Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Molecular Diagnostics Point of Care Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Molecular Diagnostics Point of Care Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Molecular Diagnostics Point of Care Market Size Market Share by Country (2021-2026)
Table 25. Americas Molecular Diagnostics Point of Care Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Molecular Diagnostics Point of Care Market Size Market Share by Type (2021-2026)
Table 27. Americas Molecular Diagnostics Point of Care Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Molecular Diagnostics Point of Care Market Size Market Share by Application (2021-2026)
Table 29. APAC Molecular Diagnostics Point of Care Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Molecular Diagnostics Point of Care Market Size Market Share by Region (2021-2026)
Table 31. APAC Molecular Diagnostics Point of Care Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Molecular Diagnostics Point of Care Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Molecular Diagnostics Point of Care Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Molecular Diagnostics Point of Care Market Size Market Share by Country (2021-2026)
Table 35. Europe Molecular Diagnostics Point of Care Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Molecular Diagnostics Point of Care Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Molecular Diagnostics Point of Care Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Molecular Diagnostics Point of Care Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Molecular Diagnostics Point of Care Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Molecular Diagnostics Point of Care
Table 41. Key Market Challenges & Risks of Molecular Diagnostics Point of Care
Table 42. Key Industry Trends of Molecular Diagnostics Point of Care
Table 43. Global Molecular Diagnostics Point of Care Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Molecular Diagnostics Point of Care Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Molecular Diagnostics Point of Care Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Molecular Diagnostics Point of Care Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Abbott Laboratories Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 48. Abbott Laboratories Molecular Diagnostics Point of Care Product Offered
Table 49. Abbott Laboratories Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Abbott Laboratories Main Business
Table 51. Abbott Laboratories Latest Developments
Table 52. Abaxis Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 53. Abaxis Molecular Diagnostics Point of Care Product Offered
Table 54. Abaxis Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Abaxis Main Business
Table 56. Abaxis Latest Developments
Table 57. Bayer Healthcare Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 58. Bayer Healthcare Molecular Diagnostics Point of Care Product Offered
Table 59. Bayer Healthcare Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Bayer Healthcare Main Business
Table 61. Bayer Healthcare Latest Developments
Table 62. Bio-Rad Laboratories Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 63. Bio-Rad Laboratories Molecular Diagnostics Point of Care Product Offered
Table 64. Bio-Rad Laboratories Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Bio-Rad Laboratories Main Business
Table 66. Bio-Rad Laboratories Latest Developments
Table 67. Becton Dickinson and Company Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 68. Becton Dickinson and Company Molecular Diagnostics Point of Care Product Offered
Table 69. Becton Dickinson and Company Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Becton Dickinson and Company Main Business
Table 71. Becton Dickinson and Company Latest Developments
Table 72. Binx Health Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 73. Binx Health Molecular Diagnostics Point of Care Product Offered
Table 74. Binx Health Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Binx Health Main Business
Table 76. Binx Health Latest Developments
Table 77. BioMerieux Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 78. BioMerieux Molecular Diagnostics Point of Care Product Offered
Table 79. BioMerieux Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. BioMerieux Main Business
Table 81. BioMerieux Latest Developments
Table 82. Co-Diagnostics Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 83. Co-Diagnostics Molecular Diagnostics Point of Care Product Offered
Table 84. Co-Diagnostics Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Co-Diagnostics Main Business
Table 86. Co-Diagnostics Latest Developments
Table 87. DanaherCorporation Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 88. DanaherCorporation Molecular Diagnostics Point of Care Product Offered
Table 89. DanaherCorporation Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. DanaherCorporation Main Business
Table 91. DanaherCorporation Latest Developments
Table 92. Dako Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 93. Dako Molecular Diagnostics Point of Care Product Offered
Table 94. Dako Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Dako Main Business
Table 96. Dako Latest Developments
Table 97. F. Hoffmann Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 98. F. Hoffmann Molecular Diagnostics Point of Care Product Offered
Table 99. F. Hoffmann Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. F. Hoffmann Main Business
Table 101. F. Hoffmann Latest Developments
Table 102. OraSure Technologies Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 103. OraSure Technologies Molecular Diagnostics Point of Care Product Offered
Table 104. OraSure Technologies Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. OraSure Technologies Main Business
Table 106. OraSure Technologies Latest Developments
Table 107. Roche Diagnostics Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 108. Roche Diagnostics Molecular Diagnostics Point of Care Product Offered
Table 109. Roche Diagnostics Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Roche Diagnostics Main Business
Table 111. Roche Diagnostics Latest Developments
Table 112. Nipro Diagnostics Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 113. Nipro Diagnostics Molecular Diagnostics Point of Care Product Offered
Table 114. Nipro Diagnostics Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Nipro Diagnostics Main Business
Table 116. Nipro Diagnostics Latest Developments
Table 117. Genestat Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 118. Genestat Molecular Diagnostics Point of Care Product Offered
Table 119. Genestat Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Genestat Main Business
Table 121. Genestat Latest Developments
Table 122. Meridian Bioscience Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 123. Meridian Bioscience Molecular Diagnostics Point of Care Product Offered
Table 124. Meridian Bioscience Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Meridian Bioscience Main Business
Table 126. Meridian Bioscience Latest Developments
Table 127. Molbio Diagnostics Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 128. Molbio Diagnostics Molecular Diagnostics Point of Care Product Offered
Table 129. Molbio Diagnostics Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. Molbio Diagnostics Main Business
Table 131. Molbio Diagnostics Latest Developments
Table 132. Siemens Healthcare Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 133. Siemens Healthcare Molecular Diagnostics Point of Care Product Offered
Table 134. Siemens Healthcare Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 135. Siemens Healthcare Main Business
Table 136. Siemens Healthcare Latest Developments
Table 137. Thermo Fisher Scientific Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 138. Thermo Fisher Scientific Molecular Diagnostics Point of Care Product Offered
Table 139. Thermo Fisher Scientific Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 140. Thermo Fisher Scientific Main Business
Table 141. Thermo Fisher Scientific Latest Developments
Table 142. Visby Medical Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 143. Visby Medical Molecular Diagnostics Point of Care Product Offered
Table 144. Visby Medical Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 145. Visby Medical Main Business
Table 146. Visby Medical Latest Developments
Table 147. Wuhan Easy Diagnosis Biomedicine Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 148. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Product Offered
Table 149. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 150. Wuhan Easy Diagnosis Biomedicine Main Business
Table 151. Wuhan Easy Diagnosis Biomedicine Latest Developments
Table 152. Beijing Tiandz Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 153. Beijing Tiandz Molecular Diagnostics Point of Care Product Offered
Table 154. Beijing Tiandz Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 155. Beijing Tiandz Main Business
Table 156. Beijing Tiandz Latest Developments
Table 157. Beijing Content Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 158. Beijing Content Molecular Diagnostics Point of Care Product Offered
Table 159. Beijing Content Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 160. Beijing Content Main Business
Table 161. Beijing Content Latest Developments
Table 1. Molecular Diagnostics Point of Care Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Molecular Diagnostics Point of Care Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Assays and Kits
Table 4. Major Players of Instruments and Analyzers
Table 5. Major Players of Software and Services
Table 6. Major Players of Others
Table 7. Molecular Diagnostics Point of Care Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Molecular Diagnostics Point of Care Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Molecular Diagnostics Point of Care Market Size Market Share by Type (2021-2026)
Table 10. Molecular Diagnostics Point of Care Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Molecular Diagnostics Point of Care Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Molecular Diagnostics Point of Care Market Size Market Share by Application (2021-2026)
Table 13. Global Molecular Diagnostics Point of Care Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Molecular Diagnostics Point of Care Revenue Market Share by Player (2021-2026)
Table 15. Molecular Diagnostics Point of Care Key Players Head office and Products Offered
Table 16. Molecular Diagnostics Point of Care Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Molecular Diagnostics Point of Care Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Molecular Diagnostics Point of Care Market Size Market Share by Region (2021-2026)
Table 21. Global Molecular Diagnostics Point of Care Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Molecular Diagnostics Point of Care Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Molecular Diagnostics Point of Care Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Molecular Diagnostics Point of Care Market Size Market Share by Country (2021-2026)
Table 25. Americas Molecular Diagnostics Point of Care Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Molecular Diagnostics Point of Care Market Size Market Share by Type (2021-2026)
Table 27. Americas Molecular Diagnostics Point of Care Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Molecular Diagnostics Point of Care Market Size Market Share by Application (2021-2026)
Table 29. APAC Molecular Diagnostics Point of Care Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Molecular Diagnostics Point of Care Market Size Market Share by Region (2021-2026)
Table 31. APAC Molecular Diagnostics Point of Care Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Molecular Diagnostics Point of Care Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Molecular Diagnostics Point of Care Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Molecular Diagnostics Point of Care Market Size Market Share by Country (2021-2026)
Table 35. Europe Molecular Diagnostics Point of Care Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Molecular Diagnostics Point of Care Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Molecular Diagnostics Point of Care Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Molecular Diagnostics Point of Care Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Molecular Diagnostics Point of Care Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Molecular Diagnostics Point of Care
Table 41. Key Market Challenges & Risks of Molecular Diagnostics Point of Care
Table 42. Key Industry Trends of Molecular Diagnostics Point of Care
Table 43. Global Molecular Diagnostics Point of Care Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Molecular Diagnostics Point of Care Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Molecular Diagnostics Point of Care Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Molecular Diagnostics Point of Care Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Abbott Laboratories Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 48. Abbott Laboratories Molecular Diagnostics Point of Care Product Offered
Table 49. Abbott Laboratories Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Abbott Laboratories Main Business
Table 51. Abbott Laboratories Latest Developments
Table 52. Abaxis Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 53. Abaxis Molecular Diagnostics Point of Care Product Offered
Table 54. Abaxis Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Abaxis Main Business
Table 56. Abaxis Latest Developments
Table 57. Bayer Healthcare Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 58. Bayer Healthcare Molecular Diagnostics Point of Care Product Offered
Table 59. Bayer Healthcare Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Bayer Healthcare Main Business
Table 61. Bayer Healthcare Latest Developments
Table 62. Bio-Rad Laboratories Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 63. Bio-Rad Laboratories Molecular Diagnostics Point of Care Product Offered
Table 64. Bio-Rad Laboratories Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Bio-Rad Laboratories Main Business
Table 66. Bio-Rad Laboratories Latest Developments
Table 67. Becton Dickinson and Company Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 68. Becton Dickinson and Company Molecular Diagnostics Point of Care Product Offered
Table 69. Becton Dickinson and Company Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Becton Dickinson and Company Main Business
Table 71. Becton Dickinson and Company Latest Developments
Table 72. Binx Health Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 73. Binx Health Molecular Diagnostics Point of Care Product Offered
Table 74. Binx Health Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Binx Health Main Business
Table 76. Binx Health Latest Developments
Table 77. BioMerieux Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 78. BioMerieux Molecular Diagnostics Point of Care Product Offered
Table 79. BioMerieux Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. BioMerieux Main Business
Table 81. BioMerieux Latest Developments
Table 82. Co-Diagnostics Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 83. Co-Diagnostics Molecular Diagnostics Point of Care Product Offered
Table 84. Co-Diagnostics Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Co-Diagnostics Main Business
Table 86. Co-Diagnostics Latest Developments
Table 87. DanaherCorporation Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 88. DanaherCorporation Molecular Diagnostics Point of Care Product Offered
Table 89. DanaherCorporation Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. DanaherCorporation Main Business
Table 91. DanaherCorporation Latest Developments
Table 92. Dako Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 93. Dako Molecular Diagnostics Point of Care Product Offered
Table 94. Dako Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Dako Main Business
Table 96. Dako Latest Developments
Table 97. F. Hoffmann Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 98. F. Hoffmann Molecular Diagnostics Point of Care Product Offered
Table 99. F. Hoffmann Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. F. Hoffmann Main Business
Table 101. F. Hoffmann Latest Developments
Table 102. OraSure Technologies Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 103. OraSure Technologies Molecular Diagnostics Point of Care Product Offered
Table 104. OraSure Technologies Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. OraSure Technologies Main Business
Table 106. OraSure Technologies Latest Developments
Table 107. Roche Diagnostics Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 108. Roche Diagnostics Molecular Diagnostics Point of Care Product Offered
Table 109. Roche Diagnostics Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Roche Diagnostics Main Business
Table 111. Roche Diagnostics Latest Developments
Table 112. Nipro Diagnostics Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 113. Nipro Diagnostics Molecular Diagnostics Point of Care Product Offered
Table 114. Nipro Diagnostics Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Nipro Diagnostics Main Business
Table 116. Nipro Diagnostics Latest Developments
Table 117. Genestat Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 118. Genestat Molecular Diagnostics Point of Care Product Offered
Table 119. Genestat Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Genestat Main Business
Table 121. Genestat Latest Developments
Table 122. Meridian Bioscience Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 123. Meridian Bioscience Molecular Diagnostics Point of Care Product Offered
Table 124. Meridian Bioscience Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Meridian Bioscience Main Business
Table 126. Meridian Bioscience Latest Developments
Table 127. Molbio Diagnostics Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 128. Molbio Diagnostics Molecular Diagnostics Point of Care Product Offered
Table 129. Molbio Diagnostics Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. Molbio Diagnostics Main Business
Table 131. Molbio Diagnostics Latest Developments
Table 132. Siemens Healthcare Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 133. Siemens Healthcare Molecular Diagnostics Point of Care Product Offered
Table 134. Siemens Healthcare Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 135. Siemens Healthcare Main Business
Table 136. Siemens Healthcare Latest Developments
Table 137. Thermo Fisher Scientific Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 138. Thermo Fisher Scientific Molecular Diagnostics Point of Care Product Offered
Table 139. Thermo Fisher Scientific Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 140. Thermo Fisher Scientific Main Business
Table 141. Thermo Fisher Scientific Latest Developments
Table 142. Visby Medical Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 143. Visby Medical Molecular Diagnostics Point of Care Product Offered
Table 144. Visby Medical Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 145. Visby Medical Main Business
Table 146. Visby Medical Latest Developments
Table 147. Wuhan Easy Diagnosis Biomedicine Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 148. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Product Offered
Table 149. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 150. Wuhan Easy Diagnosis Biomedicine Main Business
Table 151. Wuhan Easy Diagnosis Biomedicine Latest Developments
Table 152. Beijing Tiandz Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 153. Beijing Tiandz Molecular Diagnostics Point of Care Product Offered
Table 154. Beijing Tiandz Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 155. Beijing Tiandz Main Business
Table 156. Beijing Tiandz Latest Developments
Table 157. Beijing Content Details, Company Type, Molecular Diagnostics Point of Care Area Served and Its Competitors
Table 158. Beijing Content Molecular Diagnostics Point of Care Product Offered
Table 159. Beijing Content Molecular Diagnostics Point of Care Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 160. Beijing Content Main Business
Table 161. Beijing Content Latest Developments
LIST OF FIGURES
Figure 1. Molecular Diagnostics Point of Care Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Diagnostics Point of Care Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Molecular Diagnostics Point of Care Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Molecular Diagnostics Point of Care Sales Market Share by Country/Region (2025)
Figure 8. Molecular Diagnostics Point of Care Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Molecular Diagnostics Point of Care Market Size Market Share by Type in 2025
Figure 10. Molecular Diagnostics Point of Care in Tumor
Figure 11. Global Molecular Diagnostics Point of Care Market: Tumor (2021-2026) & ($ millions)
Figure 12. Molecular Diagnostics Point of Care in Hematology
Figure 13. Global Molecular Diagnostics Point of Care Market: Hematology (2021-2026) & ($ millions)
Figure 14. Molecular Diagnostics Point of Care in Endocrinology
Figure 15. Global Molecular Diagnostics Point of Care Market: Endocrinology (2021-2026) & ($ millions)
Figure 16. Molecular Diagnostics Point of Care in Infectious Disease
Figure 17. Global Molecular Diagnostics Point of Care Market: Infectious Disease (2021-2026) & ($ millions)
Figure 18. Molecular Diagnostics Point of Care in Others
Figure 19. Global Molecular Diagnostics Point of Care Market: Others (2021-2026) & ($ millions)
Figure 20. Global Molecular Diagnostics Point of Care Market Size Market Share by Application in 2025
Figure 21. Global Molecular Diagnostics Point of Care Revenue Market Share by Player in 2025
Figure 22. Global Molecular Diagnostics Point of Care Market Size Market Share by Region (2021-2026)
Figure 23. Americas Molecular Diagnostics Point of Care Market Size 2021-2026 ($ millions)
Figure 24. APAC Molecular Diagnostics Point of Care Market Size 2021-2026 ($ millions)
Figure 25. Europe Molecular Diagnostics Point of Care Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Molecular Diagnostics Point of Care Market Size 2021-2026 ($ millions)
Figure 27. Americas Molecular Diagnostics Point of Care Value Market Share by Country in 2025
Figure 28. United States Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Molecular Diagnostics Point of Care Market Size Market Share by Region in 2025
Figure 33. APAC Molecular Diagnostics Point of Care Market Size Market Share by Type (2021-2026)
Figure 34. APAC Molecular Diagnostics Point of Care Market Size Market Share by Application (2021-2026)
Figure 35. China Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 39. India Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Molecular Diagnostics Point of Care Market Size Market Share by Country in 2025
Figure 42. Europe Molecular Diagnostics Point of Care Market Size Market Share by Type (2021-2026)
Figure 43. Europe Molecular Diagnostics Point of Care Market Size Market Share by Application (2021-2026)
Figure 44. Germany Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 45. France Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Molecular Diagnostics Point of Care Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Molecular Diagnostics Point of Care Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Molecular Diagnostics Point of Care Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 58. APAC Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 59. Europe Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 61. United States Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 62. Canada Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 63. Mexico Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 64. Brazil Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 65. China Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 66. Japan Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 67. Korea Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 69. India Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 70. Australia Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 71. Germany Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 72. France Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 73. UK Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 74. Italy Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 75. Russia Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 76. Egypt Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 77. South Africa Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 78. Israel Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 79. Turkey Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 80. Global Molecular Diagnostics Point of Care Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Molecular Diagnostics Point of Care Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 1. Molecular Diagnostics Point of Care Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Diagnostics Point of Care Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Molecular Diagnostics Point of Care Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Molecular Diagnostics Point of Care Sales Market Share by Country/Region (2025)
Figure 8. Molecular Diagnostics Point of Care Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Molecular Diagnostics Point of Care Market Size Market Share by Type in 2025
Figure 10. Molecular Diagnostics Point of Care in Tumor
Figure 11. Global Molecular Diagnostics Point of Care Market: Tumor (2021-2026) & ($ millions)
Figure 12. Molecular Diagnostics Point of Care in Hematology
Figure 13. Global Molecular Diagnostics Point of Care Market: Hematology (2021-2026) & ($ millions)
Figure 14. Molecular Diagnostics Point of Care in Endocrinology
Figure 15. Global Molecular Diagnostics Point of Care Market: Endocrinology (2021-2026) & ($ millions)
Figure 16. Molecular Diagnostics Point of Care in Infectious Disease
Figure 17. Global Molecular Diagnostics Point of Care Market: Infectious Disease (2021-2026) & ($ millions)
Figure 18. Molecular Diagnostics Point of Care in Others
Figure 19. Global Molecular Diagnostics Point of Care Market: Others (2021-2026) & ($ millions)
Figure 20. Global Molecular Diagnostics Point of Care Market Size Market Share by Application in 2025
Figure 21. Global Molecular Diagnostics Point of Care Revenue Market Share by Player in 2025
Figure 22. Global Molecular Diagnostics Point of Care Market Size Market Share by Region (2021-2026)
Figure 23. Americas Molecular Diagnostics Point of Care Market Size 2021-2026 ($ millions)
Figure 24. APAC Molecular Diagnostics Point of Care Market Size 2021-2026 ($ millions)
Figure 25. Europe Molecular Diagnostics Point of Care Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Molecular Diagnostics Point of Care Market Size 2021-2026 ($ millions)
Figure 27. Americas Molecular Diagnostics Point of Care Value Market Share by Country in 2025
Figure 28. United States Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Molecular Diagnostics Point of Care Market Size Market Share by Region in 2025
Figure 33. APAC Molecular Diagnostics Point of Care Market Size Market Share by Type (2021-2026)
Figure 34. APAC Molecular Diagnostics Point of Care Market Size Market Share by Application (2021-2026)
Figure 35. China Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 39. India Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Molecular Diagnostics Point of Care Market Size Market Share by Country in 2025
Figure 42. Europe Molecular Diagnostics Point of Care Market Size Market Share by Type (2021-2026)
Figure 43. Europe Molecular Diagnostics Point of Care Market Size Market Share by Application (2021-2026)
Figure 44. Germany Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 45. France Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Molecular Diagnostics Point of Care Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Molecular Diagnostics Point of Care Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Molecular Diagnostics Point of Care Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Molecular Diagnostics Point of Care Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 58. APAC Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 59. Europe Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 61. United States Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 62. Canada Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 63. Mexico Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 64. Brazil Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 65. China Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 66. Japan Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 67. Korea Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 69. India Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 70. Australia Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 71. Germany Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 72. France Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 73. UK Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 74. Italy Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 75. Russia Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 76. Egypt Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 77. South Africa Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 78. Israel Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 79. Turkey Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
Figure 80. Global Molecular Diagnostics Point of Care Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Molecular Diagnostics Point of Care Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Molecular Diagnostics Point of Care Market Size 2027-2032 ($ millions)
